Cornell researchers have used artificial intelligence to uncover a previously unknown way cells control how proteins move ...

A man successfully operated on for skin cancer just four weeks after he went to the GP to have a mole checked says being part ...

An international research team led by Dr. Lucia Torres Fernández from the working groups of Professor Dr. Julie George and ...

Men are being offered a £99 prostate cancer test that has been found to detect more than twice as many aggressive cancers as standard screening methods.

Australian researchers have identified a promising new approach that could help stop one of the most aggressive forms of ...

Despite the revolutionary impact of immune checkpoint inhibitors on cancer therapy, 60% to 80% of patients with NSCLC still show suboptimal responses.

Solstice Oncology is advancing a medicine from China’s Harbour BioMed that it believes is able to address the weaknesses of drugs aimed at CTLA-4, a popular but tricky cancer immunotherapy target.

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Hyrnuo (sevabertinib) for adults with locally ...

Invited speaker, Stephen Kee, M.D. reviews SYNC-T™ Therapy SV-102 mechanism, previously reported Phase 1 findings and ongoing Phase 2 LEGION-100 trial in metastatic prostate cancer ...

At just 35, Tatiana McNamara got the shock of her life when a painful, swollen knee led to a diagnosis of blood cancer.

Hepatocellular carcinoma is the sixth most common malignancy and the third leading cause of cancer-related death globally.

Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, ...